Sandoz logo
Sandoz
SDZNY | OTC
Chart Builder DCF Calculator
$101.09
+$0.08 (+0.08%)
At close: Nov 16, 2026, 3:58 PM ET
$100.70
-$0.39 (-0.39%)
Pre-market: Nov 16, 2026, 11:29 AM ET

Sandoz Company Profile

Company profile explained

Company Profile

Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

Key Executives

Name Position
Richard Saynor Chief Executive Officer
Asaf Gal Chief Technology Officer
Remco J. Steenbergen Chief Financial Officer
Tripti Jha Chief People Officer
Claire D'Abreu-Hayling Chief Scientific Officer & President of Generics Development
Craig Marks Head of Investor Relations
Glenn A. Gerecke Chief Manufacturing & Supply Officer
Ingrid Sollerer General Counsel & Chief Compliance Officer
Keren Haruvi President of North America
Rebecca Guntern Chief Commercial Officer
Simon Wolfgang Hartmut Goeller Country President of Germany
Sandoz
Sandoz logo
Country Switzerland
IPO Date Oct 4, 2023
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 23,000
CEO Richard Saynor

Contact Details

Centralbahnstrasse 4 Basel, ZG 4051 Switzerland

Stock Details

Ticker Symbol SDZNY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 799926100
ISIN Number US7999261008
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.